EDN1 and endothelial dysfunction: Signaling of a receptor for endothelin-1, EDNRA, mediates activation and proliferation of VSMC, and its selective inhibitors prevent endothelial dysfunction, structural vascular change in atherosclerosis, and also inhibit cholesterol induced atherosclerosis [34–36].